Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety

Detalhes bibliográficos
Autor(a) principal: Flausino, Otavio Aparecido
Data de Publicação: 2007
Outros Autores: Pereira, Ana Maria, Bolzani, Vanderlan da Silva [UNESP], Nunes-de-Souza, Ricardo Luiz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1248/bpb.30.375
http://hdl.handle.net/11449/34195
Resumo: The effects of acute oral administration of erythrinian alkaloids, Le. (+)-alpha-hydroxy-erysotrine, erythravine and (+)-11 alpha-hydroxy-erythravine isolated from the flowers of Erythrina mulungu were investigated in two animal models of anxiety in mice-the light-dark transition model (LDTM) and the elevated plus-maze (EPM). In the LDTM, erythravine (3, 10 mg/kg) and (+)-11 alpha-hydroxy-erythravine (10mg/kg) increased the time spent by the animals in the illuminated compartment and (+)-11 alpha-hydroxy-erythravine (3 mg/kg) increased the number of transitions between compartments of the LDTM, suggesting an anxiolytic-like effect of these erythrinian alkaloids. Nevertheless, the third alkaloid studied, (+)-alpha-hydroxy-erysotrine, did not change any behavioral response with the range of doses used (3-10 mg/kg). Since the oral administration of the crude extract of E. mulungu (EM) (100-400 mg/kg) did not modify the conventional measures of anxiety in the EPM, this animal model was not chosen to evaluate the anxiolytic properties of the isolated alkaloids. These results suggest that the alkaloids erythravine and (+)-11 alpha-hydroxy-erythravine are responsible for the anxiolytic effects of the crude extract of E. mulungu.
id UNSP_0edef64c4aa4315c9f8afee4ad56911a
oai_identifier_str oai:repositorio.unesp.br:11449/34195
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxietyErythrina mulungualkaloidanxietymedicinal plantcentral nervous systemanimal modelThe effects of acute oral administration of erythrinian alkaloids, Le. (+)-alpha-hydroxy-erysotrine, erythravine and (+)-11 alpha-hydroxy-erythravine isolated from the flowers of Erythrina mulungu were investigated in two animal models of anxiety in mice-the light-dark transition model (LDTM) and the elevated plus-maze (EPM). In the LDTM, erythravine (3, 10 mg/kg) and (+)-11 alpha-hydroxy-erythravine (10mg/kg) increased the time spent by the animals in the illuminated compartment and (+)-11 alpha-hydroxy-erythravine (3 mg/kg) increased the number of transitions between compartments of the LDTM, suggesting an anxiolytic-like effect of these erythrinian alkaloids. Nevertheless, the third alkaloid studied, (+)-alpha-hydroxy-erysotrine, did not change any behavioral response with the range of doses used (3-10 mg/kg). Since the oral administration of the crude extract of E. mulungu (EM) (100-400 mg/kg) did not modify the conventional measures of anxiety in the EPM, this animal model was not chosen to evaluate the anxiolytic properties of the isolated alkaloids. These results suggest that the alkaloids erythravine and (+)-11 alpha-hydroxy-erythravine are responsible for the anxiolytic effects of the crude extract of E. mulungu.São Paulo State Univ, Pharmacol Lab, BR-14801902 Araraquara, SP, BrazilSão Paulo State Univ, Dept Organ Chem, BR-14801902 Araraquara, SP, BrazilUniv Ribeirao Preto, Dept Vegetal Biotechnol, BR-14096380 Ribeirao Preto, BrazilUniv São Paulo, FFCLRP, Dept Psychobiol, BR-14040901 Ribeirao Preto, SP, BrazilSão Paulo State Univ, Pharmacol Lab, BR-14801902 Araraquara, SP, BrazilSão Paulo State Univ, Dept Organ Chem, BR-14801902 Araraquara, SP, BrazilPharmaceutical Soc JapanUniversidade Estadual Paulista (Unesp)Univ Ribeirao PretoUniversidade de São Paulo (USP)Flausino, Otavio AparecidoPereira, Ana MariaBolzani, Vanderlan da Silva [UNESP]Nunes-de-Souza, Ricardo Luiz2014-05-20T15:23:24Z2014-05-20T15:23:24Z2007-02-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article375-378application/pdfhttp://dx.doi.org/10.1248/bpb.30.375Biological & Pharmaceutical Bulletin. Tokyo: Pharmaceutical Soc Japan, v. 30, n. 2, p. 375-378, 2007.0918-6158http://hdl.handle.net/11449/3419510.1248/bpb.30.375WOS:0002455826000322-s2.0-33846988259WOS000245582600032.pdf4484083685251673Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengBiological & Pharmaceutical Bulletin1.6940,626info:eu-repo/semantics/openAccess2023-12-24T06:15:46Zoai:repositorio.unesp.br:11449/34195Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T21:09:39.155758Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
title Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
spellingShingle Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
Flausino, Otavio Aparecido
Erythrina mulungu
alkaloid
anxiety
medicinal plant
central nervous system
animal model
title_short Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
title_full Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
title_fullStr Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
title_full_unstemmed Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
title_sort Effects of erythrinian alkaloids isolated from Erythrina mulungu (Papilionaceae) in mice submitted to animal models of anxiety
author Flausino, Otavio Aparecido
author_facet Flausino, Otavio Aparecido
Pereira, Ana Maria
Bolzani, Vanderlan da Silva [UNESP]
Nunes-de-Souza, Ricardo Luiz
author_role author
author2 Pereira, Ana Maria
Bolzani, Vanderlan da Silva [UNESP]
Nunes-de-Souza, Ricardo Luiz
author2_role author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
Univ Ribeirao Preto
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Flausino, Otavio Aparecido
Pereira, Ana Maria
Bolzani, Vanderlan da Silva [UNESP]
Nunes-de-Souza, Ricardo Luiz
dc.subject.por.fl_str_mv Erythrina mulungu
alkaloid
anxiety
medicinal plant
central nervous system
animal model
topic Erythrina mulungu
alkaloid
anxiety
medicinal plant
central nervous system
animal model
description The effects of acute oral administration of erythrinian alkaloids, Le. (+)-alpha-hydroxy-erysotrine, erythravine and (+)-11 alpha-hydroxy-erythravine isolated from the flowers of Erythrina mulungu were investigated in two animal models of anxiety in mice-the light-dark transition model (LDTM) and the elevated plus-maze (EPM). In the LDTM, erythravine (3, 10 mg/kg) and (+)-11 alpha-hydroxy-erythravine (10mg/kg) increased the time spent by the animals in the illuminated compartment and (+)-11 alpha-hydroxy-erythravine (3 mg/kg) increased the number of transitions between compartments of the LDTM, suggesting an anxiolytic-like effect of these erythrinian alkaloids. Nevertheless, the third alkaloid studied, (+)-alpha-hydroxy-erysotrine, did not change any behavioral response with the range of doses used (3-10 mg/kg). Since the oral administration of the crude extract of E. mulungu (EM) (100-400 mg/kg) did not modify the conventional measures of anxiety in the EPM, this animal model was not chosen to evaluate the anxiolytic properties of the isolated alkaloids. These results suggest that the alkaloids erythravine and (+)-11 alpha-hydroxy-erythravine are responsible for the anxiolytic effects of the crude extract of E. mulungu.
publishDate 2007
dc.date.none.fl_str_mv 2007-02-01
2014-05-20T15:23:24Z
2014-05-20T15:23:24Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1248/bpb.30.375
Biological & Pharmaceutical Bulletin. Tokyo: Pharmaceutical Soc Japan, v. 30, n. 2, p. 375-378, 2007.
0918-6158
http://hdl.handle.net/11449/34195
10.1248/bpb.30.375
WOS:000245582600032
2-s2.0-33846988259
WOS000245582600032.pdf
4484083685251673
url http://dx.doi.org/10.1248/bpb.30.375
http://hdl.handle.net/11449/34195
identifier_str_mv Biological & Pharmaceutical Bulletin. Tokyo: Pharmaceutical Soc Japan, v. 30, n. 2, p. 375-378, 2007.
0918-6158
10.1248/bpb.30.375
WOS:000245582600032
2-s2.0-33846988259
WOS000245582600032.pdf
4484083685251673
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Biological & Pharmaceutical Bulletin
1.694
0,626
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 375-378
application/pdf
dc.publisher.none.fl_str_mv Pharmaceutical Soc Japan
publisher.none.fl_str_mv Pharmaceutical Soc Japan
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808129291989286912